靜脈注射用溶劑：市場動向報告

Abstract

This Market Insight Report on Intravenous Solutions is analyzed by Type and Nutrients for the geographic regions - North America, Europe, Asia-Pacific and Rest of World. The global IV Solutions market segments include - by Type - Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients - Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimates and projections for the global IV solutions market are given by geographic regions. Business profiles of 14 major companies are discussed in the report. The report covers 54 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving IV Solutions market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is included. A total of 202 exhibits complement the text.

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

• 1. Introduction
  • History
  • Definitions
  • Intravenous
  • Intravenous Infusion
  • Parenteral
  • Enteral
  • Home Parenteral Nutrition (HPN)
  • Partial Parenteral Nutrition (PPN)
  • Total Parenteral Nutrition (TPN)
  • Benefits
  • Hazards of Intravenous Feeding
  • Segmentation of Intravenous Solutions
    • Exhibit 1: Segmentation of Intravenous Solutions Market by Type (Partial Parenteral Nutrition and Total Parenteral Nutrition) and Nutrients (Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other)
• 2. Global Market Analysis
  • Exhibit 2: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) in US$ Billion (Graphical Representation Included)
  • Exhibit 3: Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  • Market Analysis by Geographic Region
  • Analysis by Type
  • Partial Parenteral Nutrition
    • Exhibit 4: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 5: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
  • Total Parenteral Nutrition
    • Exhibit 6: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 7: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
  • Analysis by Nutrients
  • Carbohydrates
    • Exhibit 8: Carbohydrate Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 9: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World
  • Salt and Electrolytes
    • Exhibit 10: Salt and Electrolytes Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 11: Salt and Electrolytes Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Minerals and Vitamins
    • Exhibit 12: Mineral and Vitamin Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 13: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Amino-Acids
    • Exhibit 14: Amino-Acid Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 15: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
  • Other
    • Exhibit 16: Other Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
    • Exhibit 17: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
    • Exhibit 18: List of Major Global Companies
• 3. Regional Market Analysis
  • North America
    • Exhibit 19: Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    • Major Companies in North America
    • Baxter International
    • Hospira, Inc
    • Analysis by Type
    • Partial Parenteral Nutrition
      • Exhibit 20: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 21: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region US and Canada (Graphical Representation Included)
    • Total Parenteral Nutrition
      • Exhibit 22: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 23: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Analysis by Nutrients
    • Carbohydrates
      • Exhibit 24: Carbohydrate Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 25: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Salt and Electrolytes
      • Exhibit 26: Salt and Electrolyte Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 27: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Minerals and Vitamins
      • Exhibit 28: Mineral and Vitamin Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 29: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Amino-Acids
      • Exhibit 30: Amino-Acid Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 31: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
    • Other
      • Exhibit 32: Other Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 33: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  • Europe
    • Exhibit 34: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) in US$ Billion
    • Major Companies in Europe
    • B.Braun Melsungen AG
    • Fresenius Kabi AG
    • Groupe Danone
    • Laboratorios Grifols SA
    • Liqvor Pharmaceuticals
    • Nestle SA
    • Analysis by Type
    • Partial Parenteral Nutrition
      • Exhibit 35: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 36: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
    • Total Parenteral Nutrition
      • Exhibit 37: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 38: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
    • Analysis by Nutrients
    • Carbohydrates
      • Exhibit 39: Carbohydrate Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 40: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
    • Salt and Electrolytes
      • Exhibit 41: Salt and Electrolyte Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 42: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
    • Minerals and Vitamins
      • Exhibit 43: Mineral and Vitamin Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
      • Exhibit 44: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
    • Amino-Acids
      • Exhibit 45: Amino-Acid Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 46: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
    • Other
      • Exhibit 47: Other Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 48: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  • Asia-Pacific
    • Exhibit 49: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Competitor Companies in Asia-Pacific
    • Ahlcon Parenterals India Ltd.
    • Ajinomoto Co., Inc
    • Amit Biotech
    • Baxter (India) Pvt. Ltd
    • Changzhou Huichun Medical Equipment Co., Ltd.
    • Claris Lifesciences Ltd.
    • Devson Impex Pvt., Ltd.
    • Divis Laboratories Ltd.
    • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
    • Hexagon Group
    • Ibis Chemie International
    • Jiangsu Jianquan Medical Devices Co., Ltd
    • Kelun Pharmaceutical Co., Ltd
    • Kyowa Hakko Kogyo Co., Ltd.
    • Marck Biosciences Ltd.
    • Molchemie Overseas Operations
    • Otsuka Pharmaceutical Co., Ltd
    • Priya Chemicals
    • Sino-Swed Pharmaceutical Corp., Ltd.
    • Terumo Corporation
    • Wuhan Amino Acid Bio-Chemical Co., Ltd
    • Wuhan University Hoyo Co., Ltd.
    • Analysis by Type
    • Partial Parenteral Nutrition
      • Exhibit 50: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 51: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
    • Total Parenteral Nutrition
      • Exhibit 52: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 53: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
    • Analysis by Nutrients
    • Carbohydrates
      • Exhibit 54: Carbohydrate Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 55: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
    • Salt and Electrolytes
      • Exhibit 56: Salt and Electrolyte Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 57: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
    • Minerals and Vitamins
      • Exhibit 58: Mineral and Vitamin Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 59: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
    • Amino-Acids
      • Exhibit 60: Amino-Acid Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 61: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
    • Other
      • Exhibit 62: Other Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 63: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  • Rest of World
    • Exhibit 64: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Gulf Inject LLC-A Rest of World Major Company
    • Analysis by Type
    • Partial Parenteral Nutrition
      • Exhibit 65: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 66: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
    • Total Parenteral Nutrition
      • Exhibit 67: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 68: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
    • Analysis by Nutrients
    • Catbohydrates
      • Exhibit 69: Carbohydrate Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 70: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
    • Salt and Electrolytes
      • Exhibit 71: Salt and Electrolyte Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 72: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
    • Minerals and Vitamins
      • Exhibit 73: Mineral and Vitamin Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 74: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
    • Amino-Acids
      • Exhibit 75: Amino-Acid Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 76: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
    • Other
      • Exhibit 77: Other Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 78: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World

III. PRODUCT TECHNOLOGY/RESEARCH

• 1. Introduction
  • Intravenous Solutions
  • Composition
  • Application
  • Types of Intravenous Solutions
  • Large Volume Parenterals and Small Volume Parenteral
  • Intravenous versus Oral Mode of Administration
  • Risks
  • Precautions
  • Fat Emulsions
  • Dextrose
  • Plasma Expanders
  • Cyclical Parenteral Nutrition
  • Advantages of Cyclical Parenteral Nutrition
  • Intravenous Solutions Growth Trends - Global Markets
    • Exhibit 79: Global Market for Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
    • Exhibit 80: Global Consumption of Intravenous Solutions
• 2. Segmentation of Intravenous Solutions
  • Segmentation by Type
  • Growth Trends - Global Market for Intravenous Solutions by Type
    • Exhibit 81: Global Market for Intravenous Solutions by Type (TPN and PPN) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Partial Parenteral Nutrition
  • Growth Trends - Global Market of Intravenous Solutions for Partial Parenteral Nutrition
    • Exhibit 82: Global Market of Intravenous Solutions for Partial Parenteral Nutrition: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Total Parenteral Nutrition
  • Growth Trends - Global Market of Intravenous Solutions for Total Parenteral Nutrition
    • Exhibit 83: Global Market of Intravenous Solutions for Total Parenteral Nutrition: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Total Parenteral Nutrition
  • Complications
  • Complications due to Catheter Insertion
  • Metabolic Complications
  • Segmentation by Nutrients
  • Growth Trends - Global Market for Intravenous Solutions by Nutrients
    • Exhibit 84: Global Market for Intravenous Solutions by Nutrients (Other, Amino-Acids, Minerals & Vitamins, Salt & Electrolytes and Carbohydrates) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Carbohydrates
  • Growth Trends - Global Market Carbohydrate Intravenous Solutions
    • Exhibit 85: Global Market for Carbohydrate Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Carbohydrates: Source of Nutrition
  • Introduction
  • Disadvantages of Over-feeding with the Carbon Source
  • Endogenous Glucose Production and Oxidation
  • Guidelines
  • Glucose/Fat Ratio
  • Salt and Elecrtolytes
  • Growth Trends - Global Market for Salt and Electrolytes Intravenous Solutions
    • Exhibit 86: Global Market for Salt and Electrolytes Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Salt (Sodium chloride) and/ or Other Electrolytes
  • Saline
  • Concentrations
  • Minerals and Vitamins
  • Growth Trends - Global Market for Mineral and Vitamin Intravenous Solutions
    • Exhibit 87: Global Market for Mineral and Vitamin Intravenous Solutions: Geographic Regions (Rest of World, Asia-Pacific, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Minerals and Vitamins
  • Amino-Acids
  • Growth Trends - Global Market for Amino-Acid Intravenous Solutions
    • Exhibit 88: Global Market for Amino-Acid Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Amino Acids and/or Protein Hydrolysates
  • Dosage of Amino-Acid Solutions for Intravenous Use
  • Other
  • Growth Trends - Global Market for Other Intravenous Solutions
    • Exhibit 89: Global Market for Other Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, Europe and North America) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  • Fat (lipid) Emulsions
  • Plasma Extenders
  • Packaging and Identification Labeling of API' s and Intermediates
  • General
  • Packaging Materials
  • Label Issuance and Control
  • Packaging and Labeling Operations
  • Storage and Distribution
  • Warehousing Procedures
  • Distribution Procedures
  • Specific Guidance for API' s manufactured by Cell Culture/Fermentation
  • General
  • Cell Culture/Fermentation
  • Harvesting, Isolation and Purification
  • Viral Removal/Inactivation Steps
  • Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices
  • Safety Assessment Approach Used
  • Conclusions of the Safety Assessment
  • I V Infusion of Crystalloid Fluids and Drugs
  • Total Parenteral Nutrition (TPN)
  • Parenteral nutrition
  • Government of India -Policy and Regulations on Drugs
  • Drug Regulation and Control
  • Maharashtra FDA: Latest Reforms
  • Procedure for Drug Application in India
  • Import and Manufacturing Licenses and Approvals
  • Labeling Requirements
  • Drug Price Regulation
  • History of Drug Price Regulation
  • Trends in Drug Price Control - India
  • Regulations on Patent Protection
  • Finale
  • A Summary of the Chinese Pharmaceutical Market
  • Consolidating the System - The State Drug Administration
  • Pharmaceutical Regulations
  • Pricing and Reimbursement
  • Pharmaceutical Classification
  • Registration
  • Clinical Investigation
  • Legal Reform: Intellectual Property Rights
  • Conclusion
  • Application of Knowledge and Skills Framework and its Review Procedure
  • Introduction
  • Decision to Form NHS KSF
  • Purpose of Skills Framework
  • Mode of Function
  • Overview
  • Distribution of Pharmaceutical Products

IV. MARKET DYNAMICS

• 1. Market Overview
  • Economic Profile
  • Market Growth Factors
  • Global Market Analysis
    • Exhibit 90: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion(Graphical Representation Included)
    • Exhibit 91: Intravenous Solutions (2000, 2003 and 2005) - Percentage Breakdown of Global Market Value (Historic) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
    • Exhibit 92: Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
    • Exhibit 93: Intravenous Solutions (2006, 2009 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  • Analysis by Type
    • Exhibit 94: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
    • Exhibit 95: - Intravenous Solutions (2000, 2003 and 2005) - Percentage Breakdown of Global Market Value (Historic) by Type for PPN and TPN (Graphical Representation Included)
    • Exhibit 96: Intravenous Solutions (2005-2013) - Global Market Analysis (Current and Future) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
    • Exhibit 97: - Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Type for PPN and TPN (Graphical Representation Included)
  • Analysis by Nutrients
    • Exhibit 98: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other in US$ Billion (Graphical Representation Included)
    • Exhibit 99: Intravenous Solutions (2000, 2003 and 2005) - Percentage Breakdown of Global Market Value (Historic) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other (Graphical Representation Included)
    • Exhibit 100: Intravenous Solutions (2005-2013) - Global Market Analysis (Current and Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
    • Exhibit 101: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
• 2. Major Global Companies in Intravenous Solutions Industry
  • Ajinomoto Co., Inc. (Japan)
  • B. Braun Melsungen AG (Germany)
  • Baxter (India) Pvt. Ltd. (India)
  • Baxter International (USA)
  • Claris Lifesciences Ltd. (India)
  • Fresenius Kabi (Germany)
  • Gulf Inject LLC (UAE)
  • Groupe Danone (France)
  • Hospira, Inc (USA)
  • Kelun Pharmaceutical Co., Ltd. (China)
  • Kyowa Hakko Kogyo Co., Ltd. (Japan)
  • Laboratorios Grifols (Spain)
  • Liqvor Pharmaceuticals (Armenia)
  • Marck Biosciences Ltd. (India)
  • Nestle SA (Switzerland)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Sino-Swed Pharmaceutical Corp., Ltd. (China)
  • Terumo Corporation (Japan)
• 3. Competition Analysis
  • Exhibit 102: Global Clinical Nutrition Market: 2007 Percentage Market Share by Major Companies (Graphical Representation Included)
  • Exhibit 103: Global Intravenous Solution Products Market: 2007 Percentage Market Share by Major Companies (Graphical Representation Included)
  • Exhibit 104: Major Companies in Intravenous Solutions Industry - Annual Sales for 2002 through 2006 in US$ Million
  • Exhibit 105: Major Companies in Intravenous Solutions Industry - Production Volume and Capacity
• 4. Major Activities in Intravenous Solutions Industry
  • Otsuka to Acquire Busulfex® IV from PDL BioPharma
  • Hospira Obtains Marketing Authorization in the EU for Retacrit™
  • Voluven - Product for Prevention & Treatment of Severe Blood Volume Loss following Surgery - Approved by the FDA.
  • New Safety Packaging Introduced by Baxter Healthcare for High Alert Drugs
  • Ajinomoto and Calpis in Integration Deal
  • Transition to NextGen IV Immunoglobulin- Flebogamma® DIF - Concluded in record time in the US by Grifols
  • Kyowa Hakko and Kirin Groups Formalize Strategic Alliance Agreement
  • Baxter in Joint Venture with Guangzhou Baiyunshan for Parenteral Nutritional Products in China.
  • EMEA Authorizes NextGen IVIG Distribution in European Union
  • Kyowa Hakko Increases Amino Acid Prices in Europe
  • Shanghai Century Acquisition Corporation Acquires the Shares of Sichuan Kelun Pharmaceutical Co., Ltd
  • Advanced NutriSolutions Acquires Select Supplements from Kyowa Hakko
  • Mayne Pharma Acquisition Process Completed by Hospira.
  • Groupe Danone Acquires the Joint Venture Company - Calpis Ajinomoto Danone..
  • FDA issues Marketing License to Grifols for NextGen Intravenous Immunoglobulin (IVIG) in the US
  • Kyowa Hakko Releases White Paper Kit Attributed to Amino Acids and Related Compounds.
  • Symbiq™ - The Next-Gen Infusion System from Hospira
  • Health Alliance of Greater Cincinnati to Replace its Entire Fleet of IV Pumps Across Seven Hospitals
  • Amigrand Intravenous Infusion Launched Jointly by Tanabe Seiyaku and Terumo.
  • Systemic Fungal Infection Therapy AmBisome® 50 mg for Intravenous Drip Infusion - Launched
  • Kyowa Hakko Launches Lumistor™
  • The First Significantly Advanced Flexible IV Container in 3 decades..
  • A New Line of Intravenous Solutions - AVIVA from Baxter.
  • Cadence Pharmaceuticals Acquires Rights to IV APAP
  • BioScrip Inc. Launches Specialty Infusion Operations on Western Coast by Acquiring Intravenous Therapy Services
  • Boniva® - The First Intravenous Medication to treat Postmenopausal Osteoporosis, Approved by the FDA.
  • Ajinomoto Acquires Amoy Food Group from Groupe Danone.
  • FLEXBUMIN- the Flexible Container Packaged Albumin Solution from Baxter, Approved
• 5. Regional Market Analysis
  • A. North America
    • Exhibit 106: Intravenous Solutions (2005-2013) -North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    • Exhibit 107: List of Major Companies in North America
    • Analysis by Geographic Region
      • Exhibit 108: Intravenous Solutions (2005-2013) - North American Market Analysis (Current and Future) by Geographic Region for United States and Canada in US$ Billion (Graphical Representation Included)
      • Exhibit 109: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 110: Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
      • Exhibit 111: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 112: Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
      • Exhibit 113: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • A1. United States
    • Analysis by Type
      • Exhibit 114: Intravenous Solutions (2005-2013) - United States Market Analysis (Current & Future) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
      • Exhibit 115: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United States Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 116: Intravenous Solutions (2005-2013) - United States Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
      • Exhibit 117: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United States Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • A2. Canada
    • Analysis by Type
      • Exhibit 118: Intravenous Solutions (2005-2013) - Canadian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 119: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Canadian Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 120: Intravenous Solutions (2005-2013) - Canadian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 121: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Canadian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B. Europe
    • Exhibit 122: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
    • Exhibit 123: List of Major Companies in Europe
    • Analysis by Geographic Region
      • Exhibit 124: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 125: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe
    • Analysis by Type
      • Exhibit 126: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 127: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 128: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 129: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B1. Germany
    • Analysis by Type
      • Exhibit 130: Intravenous Solutions (2005-2013) - German Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 131: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of German Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 132: Intravenous Solutions (2005-2013) - German Market Analysis (Current &Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 133: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of German Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B2. France
    • Analysis by Type
      • Exhibit 134: Intravenous Solutions (2005-2013) - French Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 135: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of French Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 136: Intravenous Solutions (2005-2013) - French Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 137: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of French Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B3. United Kingdom
    • Analysis by Type
      • Exhibit 138: Intravenous Solutions (2005-2013) - United Kingdom Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 139: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United Kingdom Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 140: Intravenous Solutions (2005-2013) - United Kingdom Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 141: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United Kingdom Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B4. Switzerland
    • Analysis by Type
      • Exhibit 142: Intravenous Solutions (2005-2013) - Swiss Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 143: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Swiss Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 144: Intravenous Solutions (2005-2013) - Swiss Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 145: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Swiss Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B5. Russia
    • Analysis by Type
      • Exhibit 146: Intravenous Solutions (2005-2013) - Russian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 147: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Russian Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 148: Intravenous Solutions (2005-2013) - Russian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 149: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Russian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • B6. Rest of Europe
    • Analysis by Type
      • Exhibit 150: Intravenous Solutions (2005-2013) - Rest of Europe Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 151: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Europe Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 152: Intravenous Solutions (2005-2013) - Rest of Europe Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 153: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Europe Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • C. Asia-Pacific
    • Exhibit 154: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 155: List of Major Companies in Asia-Pacific
    • Analysis by Geographic Region
      • Exhibit 156: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 157: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 158: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 159: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 160: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 161: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • C1. Japan
    • Analysis by Type
      • Exhibit 162: Intravenous Solutions (2005-2013) - Japanese Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 163: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Japanese Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 164: Intravenous Solutions (2005-2013) - Japanese Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million
      • Exhibit 165: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Japanese Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • C2. China
    • Exhibit 166: Intravenous Solutions (2000-2013) - Chinese Volume Demand Analysis (Historic, Current and Future) in Billion Liters (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 167: Intravenous Solutions (2005-2013) - Chinese Market Analysis (Historic, Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 168: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Chinese Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 169: Intravenous Solutions (2005-2013) - Chinese Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 170: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Chinese Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • C3. India
    • Exhibit 171: Intravenous Solutions (2000-2013) - Indian Volume Demand Analysis (Historic, Current & Future) in Billion Liters (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 172: Intravenous Solutions (2005-2013) - Indian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 173: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Indian Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 174: Intravenous Solutions (2005-2013) - Indian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 175: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Indian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • C4. Australia
    • Analysis by Type
      • Exhibit 176: Intravenous Solutions (2005-2013) - Australian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 177: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Australian Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 178: Intravenous Solutions (2005-2013) - Australian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 179: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Australian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • C5. Rest of Asia-Pacific
    • Analysis by Type
      • Exhibit 180: Intravenous Solutions (2005-2013) - Rest of Asia-Pacific Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 181: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 182: Intravenous Solutions (2005-2013) - Rest of Asia-Pacific Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 183: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • D. Rest of World
    • Exhibit 184: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
    • Analysis by Geographic Region
      • Exhibit 185: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Brazil, Israel and Rest of World in US$ Million (Graphical Representation Included)
      • Exhibit 186: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Brazil, Israel and Rest of World
    • Analysis by Type
      • Exhibit 187: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 188: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 189: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 190: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • D1. Brazil
    • Analysis by Type
      • Exhibit 191: Intravenous Solutions (2005-2013) - Brazilian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 192: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Brazilian Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 193: Intravenous Solutions (2005-2013) - Brazilian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 194: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Brazilian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  • D2. Israel
    • Analysis by Type
      • Exhibit 195: Intravenous Solutions (2005-2013) - Israeli Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 196: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Israeli Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 197: Intravenous Solutions (2005-2013) - Israeli Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 198: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Israeli Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
    • Analysis by Type
      • Exhibit 199: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
      • Exhibit 200: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Type for PPN and TPN (Graphical Representation Included)
    • Analysis by Nutrients
      • Exhibit 201: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
      • Exhibit 202: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
• 6. The Industry Outlook

V. CORPORATE DIRECTORY